{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:33:11Z","timestamp":1790386391873,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/aci.0b013e32833e16e4","type":"journal-article","created":{"date-parts":[[2010,8,18]],"date-time":"2010-08-18T15:52:43Z","timestamp":1282146763000},"page":"478-485","source":"Crossref","is-referenced-by-count":106,"title":["Atopic keratoconjunctivitis and atopic dermatitis"],"prefix":"10.1097","volume":"10","author":[{"given":"Stefano","family":"Guglielmetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John KG","family":"Dart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Calder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/ACI.0b013e3282ef8674","article-title":"Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities","volume":"7","author":"Leonardi","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R2-12-20210128","first-page":"265","article-title":"Atopic keratoconjunctivitis","volume":"50","author":"Hogan","year":"1952","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/ACI.0b013e3282efd0bf","article-title":"Clinical grading of atopic keratoconjunctivitis","volume":"7","author":"Calonge","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0161-6420(91)32322-4","article-title":"Clinical features of atopic keratoconjunctivitis","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","article-title":"Allergic and immunologic disorders of the eye. Part II: ocular allergy","volume":"106","author":"Bielory","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02980.x","article-title":"The role of microorganisms in atopic dermatitis","volume":"144","author":"Baker","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0161-6420(92)31995-5","article-title":"Role of Staphylococcus aureus in chronic allergic conjunctivitis","volume":"99","author":"Tuft","year":"1992","journal-title":"Ophthalmology"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/ai.1994.v94.a55222","article-title":"Reduced secretion of IgA to skin surface of patients with atopic dermatitis","volume":"94","author":"Imayama","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0923-1811(98)00056-5","article-title":"Reduced amount of secretory component of IgA secretion in tears of patients with atopic dermatitis","volume":"19","author":"Toshitani","year":"1999","journal-title":"J Dermatol Sci"},{"key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/eye.2008.341","article-title":"The possible involvement of nasal allergy in allergic keratoconjunctivitis","volume":"23","author":"Pelikan","year":"2009","journal-title":"Eye (Lond)"},{"issue":"Suppl","key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0039-6257(93)90035-6","article-title":"Conjunctivitis of allergic origin: clinical presentation and differential diagnosis","volume":"38","author":"Friedlaender","year":"1993","journal-title":"Surv Ophthalmol"},{"issue":"Pt 3 Suppl","key":"R14-12-20210128","first-page":"21","article-title":"The origin of keratopathy in chronic allergic eye disease: a histopathological study","volume":"7","author":"Bacon","year":"1993","journal-title":"Eye (Lond)"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1167\/iovs.09-4183","article-title":"Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis","volume":"51","author":"Matsuda","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cyto.2008.07.007","article-title":"Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation","volume":"44","author":"Enriquez-de-Salamanca","year":"2008","journal-title":"Cytokine"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-6749(97)70279-3","article-title":"T-cell cytokines in chronic allergic eye disease","volume":"100","author":"Metz","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1167\/iovs.08-3365","article-title":"The role of interleukin-33 in chronic allergic conjunctivitis","volume":"50","author":"Matsuda","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-12-20210128","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0091-6749(98)70023-5","article-title":"Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases","volume":"102","author":"Hingorani","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bjo.80.6.556","article-title":"Eosinophil cationic protein in tears in allergic conjunctivitis","volume":"80","author":"Montan","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-6420(02)01767-0","article-title":"Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis","volume":"110","author":"Leonardi","year":"2003","journal-title":"Ophthalmology"},{"key":"R22-12-20210128","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaci.2009.03.008","article-title":"Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis","volume":"123","author":"Ueta","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R23-12-20210128","first-page":"1516","article-title":"Basophils in the giant papillae of chronic allergic keratoconjunctivitis","volume":"106","author":"Matsuda","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R24-12-20210128","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","article-title":"Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity","volume":"174","author":"Ying","year":"2005","journal-title":"J Immunol"},{"key":"R25-12-20210128","first-page":"1611","article-title":"Evaluation of conjunctival inflammatory status by confocal scanning laser microscopy and conjunctival brush cytology in patients with atopic keratoconjunctivitis (AKC)","volume":"15","author":"Wakamatsu","year":"2009","journal-title":"Mol Vis"},{"key":"R26-12-20210128","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.eye.6702367","article-title":"Tacrolimus ointment vs. steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis","volume":"21","author":"Nivenius","year":"2007","journal-title":"Eye (Lond)"},{"key":"R27-12-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/14740330902969441","article-title":"Long-term safety of tacrolimus ointment in atopic dermatitis","volume":"8","author":"Remitz","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"R29-12-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1468-3083.2008.02933.x","article-title":"Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids","volume":"23","author":"Zribi","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"R30-12-20210128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1399-3038.2009.00948.x","article-title":"Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children","volume":"21","author":"Tesse","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"R31-12-20210128","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","article-title":"Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis","volume":"41","author":"Kilic","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"R32-12-20210128","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":"A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"R33-12-20210128","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","article-title":"Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis","volume":"90","author":"Daniell","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R34-12-20210128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","article-title":"A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis","volume":"25","author":"Ebihara","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"R35-12-20210128","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ophtha.2007.07.025","article-title":"Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.","volume":"115","author":"Miyazaki","year":"2008","journal-title":"Ophthalmology"},{"key":"R36-12-20210128","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0161-6420(97)30144-4","article-title":"Systemic cyclosporine A in severe atopic keratoconjunctivitis","volume":"104","author":"Hoang-Xuan","year":"1997","journal-title":"Ophthalmology"},{"key":"R37-12-20210128","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3129\/i09-117","article-title":"0.05% cyclosporine a for treatment of chronic severe ocular surface disease","volume":"44","author":"Nochez","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"R38-12-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1468-3083.2009.03415.x","article-title":"ETFAD\/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis","volume":"24","author":"Darsow","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R39-12-20210128","first-page":"234","article-title":"Vernal keratopathy and its management","volume":"101","author":"Buckley","year":"1981","journal-title":"Trans Ophthalmol Soc U K"},{"key":"R40-12-20210128","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0161-6420(95)30925-6","article-title":"Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis","volume":"102","author":"Cameron","year":"1995","journal-title":"Ophthalmology"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e32833e16e4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:49:19Z","timestamp":1636562959000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201010000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e32833e16e4","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}